Literature DB >> 21191075

CD1d-restricted IFN-γ-secreting NKT cells promote immune complex-induced acute lung injury by regulating macrophage-inflammatory protein-1α production and activation of macrophages and dendritic cells.

Ji Hyung Kim1, Doo Hyun Chung.   

Abstract

Immune complex-induced acute lung injury (IC-ALI) has been implicated in various pulmonary disease states. However, the role of NKT cells in IC-ALI remains unknown. Therefore, we explored NKT cell functions in IC-ALI using chicken egg albumin and anti-chicken egg albumin IgG. The bronchoalveolar lavage fluid of CD1d(-/-) and Jα18(-/-) mice contained few Ly6G(+)CD11b(+) granulocytes, whereas levels in B6 mice were greater and were increased further by α-galactosyl ceramide. IFN-γ and MIP-1α production in the lungs was greater in B6 than CD1d(-/-) mice. Adoptive transfer of wild type (WT) but not IFN-γ-, MIP-1α-, or FcγR-deficient NKT cells into CD1d(-/-) mice caused recruitment of inflammatory cells to the lungs. Moreover, adoptive transfer of IFN-γR-deficient NKT cells enhanced MIP-1α production and cell recruitment in the lungs of CD1d(-/-) or CD1d(-/-)IFN-γ(-/-) mice, but to a lesser extent than WT NKT cells. This suggests that IFN-γ-producing NKT cells enhance MIP-1α production in both an autocrine and a paracrine manner. IFN-γ-deficient NKT cells induced less IL-1β and TNF-α production by alveolar macrophages and dendritic cells in CD1d(-/-) mice than did WT NKT cells. Taken together, these data suggest that CD1d-restricted IFN-γ-producing NKT cells promote IC-ALI by producing MIP-1α and enhancing proinflammatory cytokine production by alveolar macrophages and dendritic cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191075     DOI: 10.4049/jimmunol.1003140

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  The split personality of NKT cells in malignancy, autoimmune and allergic disorders.

Authors:  Jeff J Subleski; Qun Jiang; Jonathan M Weiss; Robert H Wiltrout
Journal:  Immunotherapy       Date:  2011-10       Impact factor: 4.196

2.  Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis.

Authors:  Ming Liu; Xiansheng Zeng; Junli Wang; Zhiping Fu; Jinsong Wang; Muyun Liu; Dunqiang Ren; Baodan Yu; Lixia Zheng; Xiang Hu; Wei Shi; Jun Xu
Journal:  Stem Cell Res Ther       Date:  2016-04-23       Impact factor: 6.832

Review 3.  Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases.

Authors:  Nicolás M S Gálvez; Karen Bohmwald; Gaspar A Pacheco; Catalina A Andrade; Leandro J Carreño; Alexis M Kalergis
Journal:  Clin Microbiol Rev       Date:  2020-12-23       Impact factor: 26.132

4.  IL-27 is elevated in acute lung injury and mediates inflammation.

Authors:  Fang Xu; Qiong Liu; Shihui Lin; Na Shen; Yibing Yin; Ju Cao
Journal:  J Clin Immunol       Date:  2013-07-11       Impact factor: 8.317

Review 5.  Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells.

Authors:  John P Driver; Darling Melany de Carvalho Madrid; Weihong Gu; Bianca L Artiaga; Jürgen A Richt
Journal:  Front Immunol       Date:  2020-10-20       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.